Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Infinera | INFN | Oct 10, 2024 | 6.63 | -0.30 |
InFinT Acquisition | IFIN | Oct 10, 2024 | 6.28 | 0.00 |
InflaRx N.V | IFRX | Oct 10, 2024 | 1.46 | -1.35 |
Inflection Point Acquisition II | IPXX | Oct 10, 2024 | 10.77 | 0.00 |
Inflection Point Acquisition II Unit | IPXXU | Oct 10, 2024 | 10.83 | 0.00 |
Infobird | IFBD | Oct 10, 2024 | 2.12 | +2.91 |
Informatica | INFA | Oct 10, 2024 | 25.94 | +1.89 |
Information Services Group | III | Oct 10, 2024 | 3.14 | -0.63 |
Information Technology ETF Vanguard | VGT | Oct 10, 2024 | 598.59 | +1.21 |
Infosys ADR | INFY | Oct 10, 2024 | 22.65 | -2.87 |
InfuSystems | INFU | Oct 10, 2024 | 6.68 | -4.57 |
ING Group ADR | ING | Oct 10, 2024 | 17.23 | -2.32 |
Ingersoll Rand | IR | Oct 10, 2024 | 98.56 | -0.31 |
Ingevity | NGVT | Oct 10, 2024 | 33.80 | -2.14 |
Ingles Markets A | IMKTA | Oct 10, 2024 | 60.97 | -1.04 |
Ingredion | INGR | Oct 10, 2024 | 133.58 | +0.02 |
Inhibikase Therapeutics | IKT | Oct 10, 2024 | 1.30 | +3.17 |
Inhibrx Biosciences | INBX | Oct 10, 2024 | 15.58 | -0.57 |
InMed | INM | Oct 10, 2024 | 0.21 | +2.19 |
InMode | INMD | Oct 10, 2024 | 16.16 | +7.38 |
INmune Bio | INMB | Oct 10, 2024 | 5.02 | -2.33 |
Innate Pharma ADR | IPHA | Oct 10, 2024 | 1.98 | -5.94 |
Inno Holdings | INHD | Oct 10, 2024 | 4.82 | +608.82 |
Innodata | INOD | Oct 10, 2024 | 15.48 | -0.51 |
Innospec | IOSP | Oct 10, 2024 | 111.71 | +0.13 |
InnovAge | INNV | Oct 10, 2024 | 5.59 | -1.41 |
Innovate | VATE | Oct 10, 2024 | 4.86 | +25.91 |
Innovation Beverage Group | IBG | Oct 10, 2024 | 1.05 | 0.00 |
Innovative Eyewear | LUCY | Oct 10, 2024 | 7.75 | +3.47 |
Innovative Industrial Properties | IIPR | Oct 10, 2024 | 129.53 | -0.64 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.